Last Updated on October 15, 2024 by The Health Master
Recall
Important Safety Information: Stop Clopez Corp has issued a voluntary recall of one specific lot of their Schwinnng capsules, a male enhancement dietary supplement.
This recall is due to the presence of an undeclared medication, Nortadalafil, which can be dangerous for certain individuals.
What’s the Problem?
- The USFDA discovered that Schwinnng capsules from Lot 2108 (EXP 10/2024) contain Nortadalafil, a medication used to treat erectile dysfunction (ED).
- This ingredient is not listed on the product label and has not been approved by the USFDA for use in dietary supplements.
- There are safety concerns because Nortadalafil can interact with nitrates, a medication commonly used for heart conditions.
- This interaction can cause a significant drop in blood pressure, potentially leading to life-threatening complications.
Who is Most at Risk?
- Men with pre-existing health conditions like diabetes, high blood pressure, high cholesterol, or heart disease are more likely to take nitrates.
- Among adult males, the target demographic for this product, those using nitrates for heart problems are at the highest risk.
- Thankfully, no adverse reactions have been reported to date.
Product Identification:
- This recall only applies to Schwinnng capsules with Lot 2108 and an expiration date of October 2024 (EXP 10/2024).
- The product was sold worldwide through Amazon.
What to Do if You Have Schwinnng Capsules:
- Stop using the product immediately.
- You can either destroy the capsules or return them to Stop Clopez Corp.
- If you choose to return, ensure you include the blister pack foil (with any remaining pills), all lot codes, a receipt as proof of purchase, and your return address.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
Drug recall: 7 lots of Treprostinil injection recalled due to this reason
Drug Recall: Sapropterin Dihydrochloride Recalled Over Potency Concerns
Drug recall: Glenmark recalls 6,528 bottles of this BP drug
Drug recall: Drugs recalled by these Indian Pharma Companies
Drug recall: Mesalamine capsules recalled Due to this reason
Drug recall: Dextroamphetamine sulfate tablets recalled Due to this reason
DCA Telangana raids crack down on Mislabeled Medicines
Is the Drugs and Magic Remedies Act Outdated ?
USFDA approval granted for Loteprednol Etabonate Eye Drops
Proposed Sale of OTC Drugs in General Stores Raises Concerns from Chemists
Empowering Regulators for Excellence: 21 Training Programs in 2024-25
USFDA inspection: With OAI observations at Sun Pharma
Specific Regulations required for New Drugs and Clinical Trial Rules for Homoeopathy
FSSAI: Food Labelling and Display – Chapter-5
USFDA Inspection: Natco Pharma Receives Positive EIR
Drug recall: 7 lots of Treprostinil injection recalled due to this reason
